250 related articles for article (PubMed ID: 26623444)
1. HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US.
Liu G; Kong L; Du P
Papillomavirus Res; 2016 Dec; 2():1-8. PubMed ID: 26623444
[TBL] [Abstract][Full Text] [Related]
2. Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009.
Hirth JM; Tan A; Wilkinson GS; Berenson AB
Cancer; 2012 Nov; 118(22):5623-9. PubMed ID: 22544681
[TBL] [Abstract][Full Text] [Related]
3. Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series.
Widdice LE; Hoagland R; Callahan ST; Kahn JA; Harrison CJ; Pahud BA; Frey SE; Berry AA; Kotloff KL; Edwards KM; Mulligan MJ; Sudman J; Nakamura A; Bernstein DI
Vaccine; 2018 Mar; 36(11):1491-1499. PubMed ID: 29428177
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing Human papillomavirus (HPV) vaccination series completion in Mississippi Medicaid.
Inguva S; Barnard M; Ward LM; Yang Y; Pittman E; Banahan BF; Kirby TR; Noble SL
Vaccine; 2020 Feb; 38(8):2051-2057. PubMed ID: 31980196
[TBL] [Abstract][Full Text] [Related]
5. Area-based socioeconomic factors and Human Papillomavirus (HPV) vaccination among teen boys in the United States.
Henry KA; Swiecki-Sikora AL; Stroup AM; Warner EL; Kepka D
BMC Public Health; 2017 Jul; 18(1):19. PubMed ID: 28709420
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus Vaccination Schedule: Adherence Among Commercially Insured Adolescents and Young Adults in the United States, 2011-2017.
Hubbard D; Shrestha S; Levitan EB; Yun H
Am J Public Health; 2020 Mar; 110(3):385-390. PubMed ID: 31944848
[No Abstract] [Full Text] [Related]
7. Acceptability of using standing orders to deliver human papillomavirus vaccines in the outpatient obstetrician/gynecologist setting.
Dempsey AF; Pyrzanowski J; Brewer S; Barnard J; Sevick C; O'Leary ST
Vaccine; 2015 Apr; 33(15):1773-9. PubMed ID: 25731788
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.
Bergman H; Buckley BS; Villanueva G; Petkovic J; Garritty C; Lutje V; Riveros-Balta AX; Low N; Henschke N
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31755549
[TBL] [Abstract][Full Text] [Related]
9. Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States.
Adjei Boakye E; Lew D; Muthukrishnan M; Tobo BB; Rohde RL; Varvares MA; Osazuwa-Peters N
Hum Vaccin Immunother; 2018; 14(8):2016-2024. PubMed ID: 29708826
[TBL] [Abstract][Full Text] [Related]
10. Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry Data.
Pathela P; Jamison K; Papadouka V; Kabir R; Markowitz LE; Dunne EF; Schillinger JA
J Adolesc Health; 2016 Dec; 59(6):710-715. PubMed ID: 27671357
[TBL] [Abstract][Full Text] [Related]
11. Postpartum HPV Vaccination Rate and Differences in Background Characteristics Between HPV Vaccinated and Unvaccinated Postpartum Women: Strict Monitoring and Follow-Up of Postpartum HPV Vaccination Program.
Lee CY; Tseng CJ; Chang CC; Lee MC; Yang SF
Front Immunol; 2021; 12():626582. PubMed ID: 34054800
[TBL] [Abstract][Full Text] [Related]
12. Predictors of Human Papillomavirus Vaccine Completion Among Low-Income Latina/o Adolescents.
Gerend MA; Stephens YP; Kazmer MM; Slate EH; Reyes E
J Adolesc Health; 2019 Jun; 64(6):753-762. PubMed ID: 30777636
[TBL] [Abstract][Full Text] [Related]
13. Human Papillomavirus Vaccination Among Adults and Children in 5 US States.
Du P; Camacho F; McCall-Hosenfeld J; Lengerich E; Meyers CM; Christensen ND
J Public Health Manag Pract; 2015; 21(6):573-83. PubMed ID: 26035648
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an Ontario cohort of grade 8 girls.
Smith LM; Brassard P; Kwong JC; Deeks SL; Ellis AK; Lévesque LE
BMC Public Health; 2011 Aug; 11():645. PubMed ID: 21838921
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital.
Schluterman NH; Terplan M; Lydecker AD; Tracy JK
Vaccine; 2011 May; 29(21):3767-72. PubMed ID: 21440038
[TBL] [Abstract][Full Text] [Related]
16. Multilevel correlates for human papillomavirus vaccination of adolescent girls attending safety net clinics.
Tiro JA; Pruitt SL; Bruce CM; Persaud D; Lau M; Vernon SW; Morrow J; Skinner CS
Vaccine; 2012 Mar; 30(13):2368-75. PubMed ID: 22108490
[TBL] [Abstract][Full Text] [Related]
17. HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US.
Saxena K; Kathe N; Sardana P; Yao L; Chen YT; Brewer NT
Hum Vaccin Immunother; 2023 Dec; 19(1):2161253. PubMed ID: 36631995
[TBL] [Abstract][Full Text] [Related]
18. A randomized intervention of reminder letter for human papillomavirus vaccine series completion.
Chao C; Preciado M; Slezak J; Xu L
J Adolesc Health; 2015 Jan; 56(1):85-90. PubMed ID: 25438965
[TBL] [Abstract][Full Text] [Related]
19. Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: a multicenter study.
Perkins RB; Brogly SB; Adams WG; Freund KM
J Womens Health (Larchmt); 2012 Aug; 21(8):813-20. PubMed ID: 22860770
[TBL] [Abstract][Full Text] [Related]
20. Inter-state variation in human papilloma virus vaccine coverage among adolescent girls in the 50 US states, 2007.
Kramer MR; Dunlop AL
Matern Child Health J; 2012 Apr; 16 Suppl 1():S102-10. PubMed ID: 22453332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
